Criam
Braga
About Criam
CRIAM offers rapid and accurate blood typing and infectious diseases detection anywhere, enabling prompt and well-informed clinical decision-making. Our stand-alone platform is portable and does not require electricity nor additional equipment or laboratory infrastructure, ensuring accessibility and usability in diverse settings. In addition, our solution is highly scalable: one reader can perform several types of tests using specific cartridges and computer vision algorithms suitable for detecting a wide range of infectious diseases, thus consolidating market penetration.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.3M
- Funding stage: Seed
- Last round: Grant (Nov 2021)
- Website: criamknowledge.com
- Phone: +351215832682
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/criam-91074 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.